In 2017, India witnessed 61.8 percent of deaths due to non-communicable diseases. NCDs majorly refer to cancers, diabetes, hypertension, cardiovascular diseases like heart attack and stroke, mental health and others

Key insights around Swine Flu and precautions by Dr. Ajay Phadke were published in Saamana Marathi Newspaper.

Find Dr. Ajay and Dr. Avinash Phadke’s original research paper on ‘Evaluation of the new Sysmex UF-5000 for determination of cutoff values for leucocytes and bacteria and utilizing in screening of Urinary Tract Infection’ linked below. Click the link to read the full article.

On the eve of antimicrobial awareness week, SRL Avinash Phadke Laboratory studied samples of over 40,500 patients and found that almost 33% harboured drug-resistant bacteria.

Dr Ajay Phadke, Centre Head, SRL Dr Avinash Phadke Labs, shares with Prathiba Raju on how automation in diagnostics sector is becoming an essential factor as it brings in efficiency, speed, precision and cost efficiency

Pathlabs in the future will be strongly backed by automation and digital technologies that will enable pathology to become more efficient and scalable

Dr Avinash Phadke, Founder, Dr Avinash Phadke Pathology Labs, and President-Technology, SRL Diagnostics, explains the opportunities and challenges within India’s diagnostics space in a chat with Raelene Kambli

Many healthcare companies today are faced with a big question. Is the business of diagnostics in India an opportunity or a challenge? By all means, most CEOs and business leaders would state self-evident opportunities such as growing demand for diagnostic services in India, expanded access to such services, increased insurance penetration and more.

The first edition of Dx Summit brought together the best minds to deliberate and debate on the right strategies to shape a sustainable future for diagnostics business in India

In genomics or specialised oncology tests there are niche areas which can further growth but larger corporates still need to look into such niche products

India’s diagnostics industry has gone through tremendous transformations in last 2-3 decades. With increasing PE investment flowing in, heightened competition, rapid tech advancements and improved quality regulations, this segment of healthcare is poised for further growth.

Disruption is said to be a critical component of innovation in any healthcare organisation. Disruption ensures that every organisation continues to focus on innovations that improves productivity, efficiency and patient satisfaction.

The Indian Express Group and Express Healthcare, through its Dx Leadership Awards, recognised and rewarded business and scientific excellence across all spectrum of diagnostics.

The industry case for hospitals to partner with established diagnostics labs to build an holistic, successful and sustainable healthcare services value chain

Tuberculosis (TB) was once feared as much as, AIDS is feared today. This social perception comes from the fact that it is a highly communicable disease and can become difficult to treat.

World Tuberculosis Day 2019: While treating TB in pregnancy is absolutely essential, the process can be a little tricky. Doctors and expecting mothers need to be extra cautious about getting the right treatment and maintaining the health of the baby as well as the mother.

The incidence of type I Diabetes is rising by three per cent every year, with nearly 75,000 new children being diagnosed to have T1DM every year. Type I Diabetes is also known as Insulin Dependent Diabetes Mellitus (IDDM) and Juvenile Onset Diabetes Mellitus. As of 2018, there were at least 97,000 cases of juvenile Diabetes reported in India alone, which is alarming.

Pathology is the science which examines the causes and effects of diseases through laboratory examination and diagnosis of samples of body tissue. In India, there are thousands of laboratories that deal in these diagnostic services.

World over, diagnostics plays a key role in the overall healthcare delivery business. It cannot be outsourced to a large extent and is completely recession proof.

Recent reports on adverse effects of MMR vaccines have reignited the age-old debate whether to vaccine or not. Industry experts and stakeholders share their views on this burning issue.